PRIME-ROSE: A blueprint for implementing precision cancer medicine in Europe.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gro Live Fagereng, Henk van der Pol, Tina Kringelbach, Ulrik Niels Lassen, Beatrice Mainoli, Kristoffer Staal Rohrberg, Edita Baltruskeviciene, Jean-Yves Blay, Katriina Johanna Jalkanen, Elisa Bjørgo, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Julio Oliveira, Sarah E. R. Halford, Matthew G. Krebs, Åslaug Helland, Loic Verlingue, Hans Gelderblom, Kjetil Tasken
Institutions: Oslo University Hospital, Leiden University Medical Center, Rigshospitalet, Copenhagen University Hospital, IPO Porto, Centro de Investigação do Instituto Português de Oncologia do Porto Francisco Gentil, RISE - Health Research Network, National Cancer Institute, Centre Léon Bérard, Helsinki University Hospital, Centraal Ziekenfonds (Netherlands), Cancer Research UK, The Christie NHS Foundation Trust
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7162493462
Cites:
Cited by:
Related to: